1.
|
20 p, 2.2 MB |
Nomenclature and clinical phenotypes of atopic dermatitis
/
Girolomoni, Giampiero (University of Verona) ;
de Bruin-Weller, Marjolein (University Medical Center (Utrecht, Netherlands)) ;
Aoki, Valeria (University of São Paulo School of Medicine) ;
Kabashima, Kenji (Kyoto University Graduate School of Medicine) ;
Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Bansal, Ashish (Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA)) ;
Rossi, Ana Beatris (Sanofi Genzyme (Cambridge, Estats Units))) ;
Universitat Autònoma de Barcelona
Atopic dermatitis is a heterogeneous disease and resists classification. In this review, we discuss atopic dermatitis nomenclature and identify morphologic phenotypes, which will facilitate correct diagnoses and development of treatment strategies. [...]
2021 - 10.1177/20406223211002979
Therapeutic Advances in Chronic Disease, Vol. 12 (march 2021)
|
|
2.
|
14 p, 1.3 MB |
Infections in Dupilumab Clinical Trials in Atopic Dermatitis : A Comprehensive Pooled Analysis
/
Eichenfield, Lawrence (Division of Pediatric and Adolescent Dermatology. Rady Children's Hospital) ;
Bieber, T. (Department of Dermatology and Allergy. Christine Kühne-Center for Allergy Research and Education. University of Bonn) ;
Beck, Lisa (University of Rochester Medical Center. Department of Dermatology) ;
Simpson, E. L. (Oregon Health and Science University. Department of Dermatology) ;
Thaçi, Diamant (Universitätsklinikum Schleswig-Holstein (Alemanya)) ;
de Bruin-Weller, Marjolein (University Medical Center Utrecht) ;
Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Silverberg, J. I. (Northwestern University Feinberg School of Medicine) ;
Ferrándiz, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Fölster-Holst, R. (University Hospital Schleswig-Holstein. Dermatology) ;
Chen, Z. (Regeneron Pharmaceuticals. Inc.) ;
Graham, N. M. H. (Regeneron Pharmaceuticals. Inc.) ;
Pirozzi, G. (Sanofi) ;
Akinlade, Bolanle (Regeneron Pharmaceuticals. Inc.) ;
Yancopoulos, G. D. (Regeneron Pharmaceuticals. Inc.) ;
Ardeleanu, Marius (Regeneron Pharmaceuticals. Inc.) ;
Universitat Autònoma de Barcelona
Background: Patients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, including skin infections and systemic infections. Immunomodulators (e. g. , anti-tumor necrosis factors, anti-interleukin [anti-IL]-23, anti-IL-17, Janus kinase inhibitors) increase risk of infections. [...]
2019 - 10.1007/s40257-019-00445-7
American Journal of Clinical Dermatology, Vol. 20 Núm. 3 (january 2019) , p. 443-456
|
|
3.
|
10 p, 285.5 KB |
Pimecrolimus in atopic dermatitis : Consensus on safety and the need to allow use in infants
/
Luger, Thomas (University of Münster. Department of Dermatology) ;
Boguniewicz, Mark (Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine) ;
Carr, Warner (Southern California Research) ;
Cork, Michael (Academic Unit of Dermatology Research, Department of Infection and Immunity, The University of Sheffield, K Floor, The Medical School (RHH Tower)) ;
Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Eichenfield, Lawrence (Departments of Pediatrics and Medicine, University of California, San Diego School of Medicine, Rady Children's Hospital) ;
Eigenmann, Philippe (Pediatric Allergy Unit, Children's University Hospital) ;
Fölster-Holst, Regina (Department of Dermatology, University Clinics of Schleswig-Holstein) ;
Gelmetti, Carlo (Department of Pathophysiology and Transplantation, University of Milan, Clinica Dermatologica, Fondazione I.R.C.C.S. Ca' Granda "Ospedale Maggiore Policlinico") ;
Gollnick, Harald (Department of Dermatology & Venereology, Otto-von-Guericke University of Magdeburg) ;
Hamelmann, Eckard (Allergy Center Ruhr, Ruhr-University Bochum, & Evangelisches Krankenhaus Bielefeld, Klinik für Kinder und Jugendmedizin) ;
Hebert, Adelaide A. (Departments of Dermatology and Pediatrics, The University of Texas Medical School-Houston) ;
Muraro, Antonella (Food Allergy Referral Centre, Department of Woman and Child Health, University Hospital of Padua) ;
Oranje, Arnold P. (Intermedica Dermatology and Hair Clinic) ;
Paller, Amy S. (Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine) ;
Paul, Carle (Dermatology Department, INSERM 1056, Paul Sabatier University, Larrey Hospital) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Ring, Johannes (Technische Universität München) ;
Siegfried, Elaine (Departments of Pediatrics and Dermatology, Saint Louis University School of Medicine) ;
Spergel, Jonathan M. (Children's Hospital of Philadelphia (Pennsilvània)) ;
Stingl, Georg (Department of Dermatology, Medical University of Vienna) ;
Taieb, Alain (Service de Dermatologie et Dermatologie Pédiatrique Centre de référence pour les maladies rares de la peau, INSERM 1035, Université de Bordeaux) ;
Torrelo, Antonio (Hospital Infantil Universitario Niño Jesús (Madrid)) ;
Werfel, Thomas (Department of Dermatology and Allergy, Hannover Medical School) ;
Wahn, Ulrich (Department of Pediatric Pneumology and Immunology, Charite) ;
Universitat Autònoma de Barcelona
Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long-term management with anti-inflammatory compounds. [...]
2015 - 10.1111/pai.12331
Pediatric Allergy and Immunology, Vol. 26 (april 2015) , p. 306-315
|
|